Tenet Healthcare Corporation
THC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.22 | -0.23 | 0.08 |
| FCF Yield | 9.12% | 21.13% | 6.15% | 10.43% |
| EV / EBITDA | 3.42 | 6.33 | 6.32 | 6.00 |
| Quality | ||||
| ROIC | 18.51% | 8.60% | 7.61% | 9.94% |
| Gross Margin | 39.72% | 37.98% | 36.76% | 37.30% |
| Cash Conversion Ratio | 0.50 | 1.81 | 1.08 | 1.06 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.53% | 1.79% | 2.82% | 1.78% |
| Free Cash Flow Growth | -31.24% | 405.61% | -64.73% | -68.26% |
| Safety | ||||
| Net Debt / EBITDA | 1.64 | 4.07 | 4.62 | 3.62 |
| Interest Coverage | 7.21 | 2.79 | 2.62 | 3.11 |
| Efficiency | ||||
| Inventory Turnover | 36.00 | 31.00 | 29.94 | 31.82 |
| Cash Conversion Cycle | 26.16 | 31.91 | 32.82 | 34.56 |